I personally found that Vyvanse did two things: raise my heart rate to unsafe levels, and allow me to focus easier without the ability to choose what I focused on.
Well, I can say for certain a whole bunch of devs were/are out of a job specifically due to the merger, so she’s certainly correct on that point. Prices… one could argue the tariffs and general iffyness about the economy are driving those.
I can’t wait for the bottom to fall out from under all this AI bullshit…